Yüklüyor......
US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018
BACKGROUND/AIMS: The US Food and Drug Administration (FDA) outlines clinical studies as postmarketing requirements and commitments to be fulfilled following FDA approval of new drugs and biologics (“therapeutics”). Regulators have increasingly emphasized lifecycle evaluation of approved therapeutics...
Kaydedildi:
| Yayımlandı: | Clin Trials |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8292154/ https://ncbi.nlm.nih.gov/pubmed/33863236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17407745211005044 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|